Haji, Shotaro http://orcid.org/0000-0003-4768-0317
Sako, Wataru http://orcid.org/0000-0003-2009-2486
Murakami, Nagahisa http://orcid.org/0000-0001-8270-4025
Osaki, Yusuke http://orcid.org/0000-0001-6588-5442
Izumi, Yuishin http://orcid.org/0000-0002-3048-9041
Article History
Received: 18 April 2024
Revised: 16 June 2024
Accepted: 17 June 2024
First Online: 2 July 2024
Declarations
:
: SH has received honoraria from AbbVie Inc., Kyowa Kirin Co. Ltd, and Sumitomo Pharma Co. Ltd. WS has received honoraria from AbbVie Inc., Eisai Co. Ltd, Kyowa Kirin Co. Ltd, Ono Co. Ltd, Sumitomo Pharma Co. Ltd, and Takeda Pharmaceutical Co. Ltd; has received research support from Mitsubishi Tanabe Pharma Co. and JSPS KAKENHI. YI has received honoraria from Mitsubishi Tanabe Pharma Co.; has received research support from Sumitomo Pharma Co. Ltd and Eisai Co. Ltd. Other authors report no competing interests.
: No ethical approval was seeked as only data from previously published studies in which informed consent was obtained were retrieved and analyzed.